Each point was worked out with the data available that day. Scale 0-10: 5 is the index average and 10 is the cap (+3 standard deviations), not perfection. The vertical axis zooms to fit this company, so two charts are not comparable by eye.
Market and Valuation
Price & Market
Prev Close Price:$254.33
Open:$252.91
Day's Low:$252.93
Day's High:$256.51
Bid / Ask:-
Market Cap:58.57B
Enterprise Value:64.45B
52-Week Range
52-Week Low:$180.45
52-Week High:$259.84
Current position in 52-week range
52w Low-52w High
50-Day Avg:$238.27
200-Day Avg:$222.36
Volume
Volume Today:1,495,411
Avg Volume (3m):1,779,759
Avg Volume (10d):1,666,080
52-Week Change:+30.20%
vs S&P 500, 52 weeks:-
Beta:0.52
Valuation Multiples
P/E (trailing):34.98
Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Aug 11, 2026. The P/E is the price divided by that EPS.
P/E (forward):17.99
PEG Ratio:1.27
Price / Book:-
Price / Sales (TTM):0.23
EV / Revenue:0.25
EV / EBITDA:15.19
Dividends
Current yield:0.81%
Annual Dividend Rate:$2.06
Dividend Trailing:$2.05
Yield Trailing:0.81%
5-Year Avg Yield:1.66%
Payout Ratio:28.33%
Last Ex-Dividend Date:-
Valuation Context
P/E vs sector (indicative)
Most Recent Quarter:-
Fiscal Year (Next):-
Loading historical OHLCV database...
Date
Open
High
Low
Close
Volume
Financial Statements TTM (Trailing 12 Months)
Income Statement
Total Revenue (TTM):254.25B
Gross Profit:9.77B
EBITDA:4.24B
Net Income (TTM):1.71B
Rev Growth (YoY):+5.80%
Earnings Growth (YoY):+68.80%
Quarterly earnings growth (YoY):+66.50%
Margins
Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-
Per Share
EPS Trailing (TTM):$7.23
Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Aug 11, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$14.06
Revenue Per Share:$1,077.32
Cash Per Share:-
Book Value:$-12.37
Last Dividend:-
Ex-Dividend Date:-
Last Split:-
Balance Sheet & Liquidity
Total cash:4.86B
Total Debt:10.00B
Net Debt (Debt - Cash):5.14B
Debt / Equity:-
Current Ratio:0.88
Quick Ratio:0.43
Cash Flows
Operating Cash Flow:5.17B
Free Cash Flow (FCF):4.75B
FCF Yield (FCF / Market Cap):-
Enterprise Value:64.45B
EV / Revenue:0.25
EV / EBITDA:15.19
Profitability
ROE (Return on Equity):-
ROA (Return on Assets):3.72%
P/E (trailing):34.98
P/E (forward):17.99
Price / Book:-
PEG Ratio:1.27
52-Week Change:+30.20%
S&P 500 change, 52 weeks:+11.37%
Historical Evolution (Last 4 Years)
Income Statement
Balance Sheet
Cash Flow
EPS and Earnings Per Share
Key EPS Metrics
EPS Trailing (TTM):$7.23
Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Aug 11, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$14.06
P/E (forward):17.99
PEG Ratio:1.27
Growth and Margins
Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-
Per Share
Revenue Per Share:$1,077.32
Cash Per Share:-
Book Value:$-12.37
Cash Flows (TTM)
Free Cash Flow:4.75B
Operating Cash Flow:5.17B
EBITDA:4.24B
Total Revenue (TTM):254.25B
Net Income (TTM):1.71B
Fiscal Year (Last):-
EPS Surprise History - Last 4 Quarters
Actual vs. Analyst Estimates · Green = beat expectations · Red = missed
Quarter
Period
Actual EPS
Estimated EPS
Difference
Surprise %
Currency
Ownership Structure
Ownership Distribution
% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float
Shares & Short Interest
Shares Outstanding:231,559,345
Float (free shares):232,133,834
Short interest (shares):7,678,341
Short % of float:-
Short Ratio (days to cover):4.16
Short interest, prior month:-
Short Interest Date:-
Governance Score (1=Best, 10=Worst)
Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-
Top Institutional Holders
Position Change: ▲ Increased · ▼ Reduced · = Unchanged
Organization
Report Date
% Shares
No. Shares
Value (USD)
Change %
Top Mutual Funds
Position Change: ▲ Increased ▼ Decreased = Unchanged
Fund
Report Date
% Shares
No. Shares
Value (USD)
Change %
Recent Insider Trades
Executive / Insider
Title
Date
Action
Shares
Options Chain
CALLS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
PUTS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
Sentiment Metrics
Put/Call Ratio (Volume):-
Put/Call Ratio (O.I.):-
Max Pain (estimated):-
Total O.I. Calls:-
Total O.I. Puts:-
Expected move
Average IV (Calls ATM):-
Average IV (Puts ATM):-
Days to Expiration:-
Expected move (±):-
Cardinal Health, Inc. (CAH) SEC filings: 10-K, 10-Q and 8-K
Direct links to financial reports filed with the SEC.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment
60
2.06M
Ms. Mary C. Scherer
Senior VP & Chief Accounting Officer
-
-
Mr. David Frost
Vice President of Investor Relations
-
-
Ms. Valerie Christine Pitteroff
Chief Human Resources Officer
54
-
You have seen the engine room
A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.
No card. No spam.
Cardinal Health, Inc. (CAH): Quantitative Analysis
Cardinal Health, Inc. (CAH) — Healthcare — Medical Distribution. CAH is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.
So far in 2026, CAH has returned +24.1% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.
CAH ranks 155 of 461 on today's multifactor score, and 16 of the 55 Healthcare companies that score. Its strongest factor is value (Z 1.32, ranked 24 of 489); its weakest is quality (Z -1.28, ranked 464 of 468). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.
Factor scores
The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.
Frequently asked questions about Cardinal Health (CAH)
When does Cardinal Health report earnings?
According to Nasdaq's public calendar (checked on Nov 4, 2026), Cardinal Health will report its next earnings on Nov 5, 2026, before the US market opens. The date is announced by the company itself and can change. Of its last 12 earnings announcements: 12 before the open (SEC filings through Aug 11, 2026). CAH earnings dates and times, quarter by quarter →
What is Cardinal Health's P/E ratio?
Cardinal Health's P/E (price over earnings per share for the last twelve months) is 35.0 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Jun 30, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Cardinal Health is above its sector median. Healthcare stocks, company by company →
Where does Cardinal Health rank on Quant500?
In the Nov 3, 2026 multi-factor ranking, Cardinal Health ranks 155 of 461, and 16 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking →How it is calculated →
Have Cardinal Health insiders bought or sold shares?
SEC Form 4 shows no open-market purchase of Cardinal Health shares from August 2025 through Nov 3, 2026. The latest sale was on Aug 19, 2026, by an officer, for $10.5M. In total, from August 2025 through Nov 3, 2026: 0 purchases and 11 sales by directors, officers and large shareholders. All CAH insider trades →
Does Cardinal Health pay a dividend?
Yes. Its dividend yield is 0.81% at the Nov 3, 2026 close (annual dividend of $2.06 per share). The latest recorded ex-dividend date is Oct 1, 2026.
What sector is Cardinal Health in, and which index?
Cardinal Health is classified in the Healthcare sector (industry: Medical Distribution), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →
What is behind these numbers
The concepts on this page, explained from scratch in the Academy. Free, no account.
Quality and low volatilityWhere the quality score comes from, and why it is the factor with the most competing definitions, all of them called the same thing.
We save the portfolios you design, your own portfolio and your Academy progress, synced across devices.
Free, no card. Two automatic emails and no more: the one that confirms your address and the welcome one. After that, nothing you do not switch on yourself in your profile — such as the alert for insider buys, the same day they are reported to the SEC.